HE WEI-WU purchased 15.8% of their position (88.15K shares) of CASI PHARMACEUTICALS, INC (DE) on the open market
Open‑market purchase worth $272.5K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 6/17/2022ACC: 0001104659-22-072392
Director10% Owner
Since Dec 2018
+88.15K
Net shares
Net buyer
$272.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
88.15K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+36.06K
Price / share
$2.97
Trade value
$107.09K
% of position
6.5%
6/13/2022
556.40K→592.46K
Common Stock
Direct
Shares
+2.10K
Price / share
$3.06
Trade value
$6.41K
% of position
0.4%
6/14/2022
592.46K→594.55K
Common Stock
Direct
Shares
+50K
Price / share
$3.18
Trade value
$159K
% of position
8.4%
6/15/2022
594.55K→644.55K
Total
Net shares
+88.15K
Net value
$272.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2022 | P · Purchase | +36.06K | $2.97 | $107.09K | 6.5% | 556.40K | 592.46K |
| Common Stock Direct | 6/14/2022 | P · Purchase | +2.10K | $3.06 | $6.41K | 0.4% | 592.46K | 594.55K |
| Common Stock Direct | 6/15/2022 | P · Purchase | +50K | $3.18 | $159K | 8.4% | 594.55K | 644.55K |
| Total | +88.15K | $272.51K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned300K
Common Stock
IndirectShares owned44.11K
Common Stock
IndirectShares owned753.23K
Total
1.10M indirect1.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300K | Indirect |
| Common Stock | 44.11K | Indirect |
| Common Stock | 753.23K | Indirect |
| Total | 1.10M | 1.10M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported